Abstract
Purpose of Review
While rheumatic disease registries collect longitudinal patient information, longitudinal analytic methods are usually not applied to these data. This review will showcase advances in longitudinal designs/analyses, and ways to leverage digital technologies to recruit and retain more registry participants.
Recent Findings
We will show how the accelerated cohort and longitudinal multiform methods are more efficient than traditional longitudinal designs. We illustrate how a smartphone app is used to recruit participants for a new rheumatic disease registry in the USA. Examples of newer longitudinal techniques applied in myositis and childhood-onset lupus are also presented.
Summary
Applying high-efficiency longitudinal design and analysis let investigators leverage the rich registry information collected over time. They allow more sophisticated and precise questions to be asked about the disease course of myositis and other rheumatic diseases, which in turn will inform the practice of clinicians and important decisions made by stakeholders.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Sokka T, Pincus T. Most patients receiving routine care for rheumatoid arthritis in 2001 did not meet inclusion criteria for most recent clinical trials or american college of rheumatology criteria for remission. J Rheumatol. 2003;30(6):1138–46.
Sokka T, Pincus T. Eligibility of patients in routine care for major clinical trials of anti-tumor necrosis factor alpha agents in rheumatoid arthritis. Arthritis Rheum. 2003;48(2):313–8.
Singer JD, Willett JB. Applied longitudinal data analysis: Modeling change and event occurrence. New York, New York: Oxford university press; 2003.
Singer JD, Willett JB, Willett JB. Applied longitudinal data analysis: modeling change and event occurrence: Oxford University Press; 2003.
• Lim LS, Pullenayegum E, Moineddin R, Gladman DD, Silverman ED, Feldman BM. Methods for analyzing observational longitudinal prognosis studies for rheumatic diseases: a review & worked example using a clinic-based cohort of juvenile dermatomyositis patients. Pediatr. 2017;15(1):18 Good review of methods for clinician investigators looking to start using longitudinal methods.
Little RJ. Methods for handling missing values in clinical trials. J Rheumatol. 1999;26(8):1654–6.
Rubin DB. Inference and missing data. Biometrika. 1976;63(3):581–92.
Graham JW. Missing data analysis: making it work in the real world. Annu Rev Psychol. 2009;60:549–76.
Graham J. Missing data: analysis and design. New York: Springer; 2012.
Galbraith S, Bowden J, Mander A. Accelerated longitudinal designs: an overview of modelling, power, costs and handling missing data. Stat Methods Med Res. 2014. https://doi.org/10.1177/0962280214547150.
Laursen BP, Little TD, Card NA. Handbook of developmental research methods. New York, New York: Guilford Press; 2011.
Moerbeek M. The effects of the number of cohorts, degree of overlap among cohorts, and frequency of observation on power in accelerated longitudinal designs. Methodology. 2011.
Keyes KM, Utz RL, Robinson W, Li G. What is a cohort effect? Comparison of three statistical methods for modeling cohort effects in obesity prevalence in the United States, 1971-2006. Soc Sci Med. 2010;70(7):1100–8.
Tomblin JB, Harrison M, Ambrose SE, Walker EA, Oleson JJ, Moeller MP. Language outcomes in young children with mild to severe hearing loss. Ear Hear. 2015;36(Suppl 1):76S–91S.
• Lim LSH, Feldman BM, Lix LM. Alternative Design and Analytical Techniques for Longitudinal Rheumatology Studies: Improved Understanding of Outcomes. Rheumatic Disease Clinics. 2018;44(2):189–201 Good overview of alternative longitudinal designs and how to conduct longitudinal studies more efficiently.
Little TD, Rhemtulla M. Planned missing data designs for developmental researchers. Child Devel Perspect. 2013;7(4):199–204.
Rhemtulla M, Little TD. Planned missing data designs for research in cognitive development. J Cogn Dev. 2012;13(4):425–38.
Kotrlik J, Williams H. The incorporation of effect size in information technology, learning, information technology, learning, and performance research and performance research. Information Technology, Learning, and Performance Journal. 2003;21(1):1
Jorgensen TD, Rhemtulla M, Schoemann A, McPherson B, Wu W, Little TD. Optimal assignment methods in three-form planned missing data designs for longitudinal panel studies. Int J Behav Dev. 2014;38(5):397–410.
Newzoo. Top 50 countries/markets by smartphone users and penetration [Internet]. Newzoo 2018. Available from: https://newzoo.com/insights/rankings/top-50-countries-by-smartphone-penetration-and-users/. Accessed 20 June 2019.
Apple. Researchkit: Apple. Available from: http://researchkit.org.
ResearchStack: ResearchStack. Available from: http://researchstack.org. Accessed 20 June 2019.
Trends CR. Unhappy with Researchkit? 5 Good Alternatives Clinical Research Trends- The Blog2017. Available from: https://www.clinicalresearchtrends.com/index.php/2017/01/16/5-good-alternatives-researchkit/. Accessed 20 June 2019.
•• Chan YY, Wang P, Rogers L, Tignor N, Zweig M, Hershman SG, et al. The Asthma Mobile Health Study, a large-scale clinical observational study using ResearchKit. Nat Biotechnol. 2017;35(4):354–62 Example of a first generation clinical study conducted using Apple’s ResearchKit platform. This reference included information about the registry setup and methods.
• Vhaduri S, Poellabauer C. Design factors of longitudinal smartphone-based health surveys. J Healthc Inform Res. 2017;1(1):52–91 Methodological considerations for smartphone surveys.
• Nowell WB, Curtis D, Thai M, Wiedmeyer C, Gavigan K, Venkatachalam S, et al. Digital interventions to build a patient registry for rheumatology research. Rheum Dis Clin North Am. 2019;45(2):173–86 Example of using smartphone to collect data in a patient registry.
•• ArthritisPower. Arthritis power: keep track of your symptoms and help advance research 2019. Available from: https://arthritispower.creakyjoints.org/#about. Accessed 20 June 2019. Website of Arthritis Power. Resource for seeing the smartphone-enabled patient registry in action.
Yun H, Nowell WB, Curtis D, Willig J, Yang S, Auriemma M, et al. Assessing RA disease activity with PROMIS measures using digital technology. Arthritis Care Res (Hoboken). 2019.
Measures H. PROMIS Northwestern University2019. Available from: http://www.healthmeasures.net/explore-measurement-systems/promis. Accessed 20 June 2019.
Dorsey ER, Yvonne Chan YF, McConnell MV, Shaw SY, Trister AD, Friend SH. The use of smartphones for health research. Acad Med. 2017;92(2):157–60.
Winer BJ. Statistical principles in experimental design. 2nd ed. New York: McGraw-Hill; 1971.
Nagin D, Tremblay RE. Trajectories of boys’ physical aggression, opposition, and hyperactivity on the path to physically violent and nonviolent juvenile delinquency. Child Dev. 1999;70(5):1181–96.
Raudenbush SW, Chan WS. Application of a hierarchical linear model to the study of adolescent deviance in an overlapping cohort design. J Consult Clin Psychol. 1993;61(6):941–51.
Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988;44(4):1049–60.
Commenges D. Multi-state models in epidemiology. Lifetime Data Anal. 1999;5(4):315–27.
Lim LS, Lefebvre A, Benseler S, Silverman ED. Longterm outcomes and damage accrual in patients with childhood systemic lupus erythematosus with psychosis and severe cognitive dysfunction. J Rheumatol. 2013;40(4):513–9.
Lin H, Scharfstein DO, Rosenheck RA. Analysis of longitudinal data with irregular, outcome-dependent follow-up. J R Stat Soc Ser B Stat Methodol. 2004;66(3):791–813.
• Blom KJ, Takken T, Huijgen BCH, Wienke J, van Royen-Kerkhof A, van Brussel M. Trajectories of cardiorespiratory fitness in patients with juvenile dermatomyositis. Rheumatology (Oxford). 2017;56(12):2204–11 Example of applying mixed random effects modeling in juvenile dermatomyositis.
• van Dijkhuizen EHP, De Iorio M, Wedderburn LR, Deakin CT, Jdrg. Clinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study. Arthritis Res Ther. 2018;20(1):180 Example of an application of joint modeling in juvenille dermatomyositis.
• van Dijkhuizen EP, Deakin CT, Wedderburn LR, De Iorio M. Modelling disease activity in juvenile dermatomyositis: a Bayesian approach. Stat Methods Med Res. 2019;28(1):35–49 Technical paper on joint modeling as applied in the juvenile dermatomyositis national cohort data for an audience interested in the technical aspects of the modeling setup.
Tsiatis A, Davidian M. Joint modeling of longitudinal and time-to-event data: an overview. Stat Sin. 2004;14:809–34.
Steyerberg EW, Moons KG, van der Windt DA, Hayden JA, Perel P, Schroter S, et al. Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Med. 2013;10(2):e1001381.
Hingorani AD, Windt DA, Riley RD, Abrams K, Moons KG, Steyerberg EW, et al. Prognosis research strategy (PROGRESS) 4: stratified medicine research. BMJ. 2013;346:e5793.
Lim LSH, Feldman BM, Lix LM. Alternative Design and Analytical Techniques for Longitudinal Rheumatology Studies: Improved Understanding of Outcomes. Rheumatic Disease Clinics. 2018;44(2):189–201.
Muthen B. Finite mixture modeling with mxture outcomes using the EM algorithm. Biometrics. 1999;55:463–9.
Gladman DD, Urowitz MB. The SLICC/ACR damage index: progress report and experience in the field. Lupus. 1999;8(8):632–7.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Inflammatory Muscle Disease
Rights and permissions
About this article
Cite this article
Lim, L.S.H., Feldman, B.M. Using Registry Data to Understand Disease Evolution in Inflammatory Myositis and Other Rheumatic Diseases. Curr Rheumatol Rep 22, 2 (2020). https://doi.org/10.1007/s11926-019-0874-1
Published:
DOI: https://doi.org/10.1007/s11926-019-0874-1